Compare LINK & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | PLUR |
|---|---|---|
| Founded | 1984 | 2001 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 12.5M |
| IPO Year | 2007 | 2026 |
| Metric | LINK | PLUR |
|---|---|---|
| Price | $2.81 | $1.07 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.4K | ★ 62.2K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.83 | 31.46 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,890,000.00 | $1,016,000.00 |
| Revenue This Year | $40.45 | $902.46 |
| Revenue Next Year | $19.16 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $2.66 | $0.85 |
| 52 Week High | $6.50 | $4.12 |
| Indicator | LINK | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | 43.59 |
| Support Level | $2.90 | $0.88 |
| Resistance Level | $3.38 | $1.43 |
| Average True Range (ATR) | 0.27 | 0.13 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 15.06 | 7.14 |
Interlink Electronics Inc is a provider of sensing technologies and printed electronics solutions that enable Human-Machine Interface (HMI) devices and Internet-of-Things (IoT) applications. Its broad product and technology portfolio spans force and touch sensors, piezoelectric sensors, rugged HMI sensors, wearable and textile-based sensors and electrochemical gas and environmental sensors, along with instruments and fully integrated systems based on its sensor technologies. It serves blue-chip customers and emerging companies across diverse end-use markets, including medical, industrial, automotive, consumer electronics, wearables, environmental monitoring, and specialty applications. It operates in single segment: the design, development, and manufacture of sensor technologies.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.